APA (7th ed.) Citation

Y, P., M, R., J, S., B, S., RF, R., J, C., . . . JD, S. (2024). Transitioning to Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: Trends and Surgical Outcomes in a Regionalized Pulmonary Oncology Network. Clinical lung cancer, 25(3), e133. https://doi.org/10.1016/j.cllc.2023.12.005

Chicago Style (17th ed.) Citation

Y, Pilon, et al. "Transitioning to Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: Trends and Surgical Outcomes in a Regionalized Pulmonary Oncology Network." Clinical Lung Cancer 25, no. 3 (2024): e133. https://doi.org/10.1016/j.cllc.2023.12.005.

MLA (9th ed.) Citation

Y, Pilon, et al. "Transitioning to Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: Trends and Surgical Outcomes in a Regionalized Pulmonary Oncology Network." Clinical Lung Cancer, vol. 25, no. 3, 2024, p. e133, https://doi.org/10.1016/j.cllc.2023.12.005.